||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Collagen Sol Share Discussion Threads
Showing 476 to 500 of 500 messages
|this is just going to drift down coz investors are going to get fed up waiting for this to move and go to pastures new and l might be one of them.|
|Why does chairman receive shares when the company makes an acquisition?...|
the ghost who walks
|Couldnt agree more inter. GEC is a prime example where we could have made some dosh with day trading but waiting for this to move, the oportunity has passed me by.|
|Petewy- please note the date when this 'buy' rating was issued and compare the price target to where we are today. Stocks like this drive me nuts. I mean they promise much and there are some serious new technology areas emerging where canny investors can place a modest stake and perhaps hope to get ten bagger - or more- returns. Or you could study the form book and back a horse. The gates open and within a short while you know if you've won or lost and have some excitement on the way. But companies like COS just keep you hanging on... and on.... and on and faithful investors hang on .... and on.... and meanwhile other opportunities are slipping by, the grandchildren are growing up, the grim reaper is knocking on your door, the grass needs trimming 'cos it's growing faster than your stock and life just passes by. My plea to the management team? For God's sake guys- DO SOMETHING|
|Google search produced:
8/11/2015 – Collagen Solutions had its “Buy” rating reiterated by analysts at Panmure Gordon. They now have a GBP 18.00p price target on the stock.
Only one stockbroker quote.|
|l've got snails that move quicker than this.|
|anyone go to agm and pick anything up ? Feedback ongoing business etc? Cheers|
|This share needs news to give it a boost.|
|Kicking in again .. Already rosey platform but plenty potentials out there that will change bottom line ... And make cos fly.. I look forward to seeing story unfold further.. As I've said before long term hold . Dyor|
|Move up soon imo|
|Below is quote from Hardman and Co report July 19th
Valuation: Our DCF valuation has risen 16% to £54m or 32p per share on the
back of these improved results. There are few quoted competitors that could be
considered as comparator companies for valuation purposes. The closest,
Innocoll, is developing proprietary products and commands an EV of £140m.|
|babbler- where did you get valuation at 32p from?|
|"Collagen Solutions is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, in vitro diagnostics, and regenerative medicine... Investment summary: 2016 was transformational for COS, the new leadership team has realigned strategy onto an accelerated growth platform, whilst maintaining core objectives. Investment in new opportunities (China JV and Orthomimetics) continues to build a pipeline of strategic relationships that should drive long term growth, whilst delivering short term financial objectives."
Hardman&Co broker note out this morning: Https://www.research-tree.com/Company/GB00B94T6Y14|
|32p valuation 8.75 p to buy. Even if playing safe and say half that valuation meant around a double bag here.|
|yes and l noticed that 225k didn't have much effect on the share price|
|No, but today's sells took a bit of the cream off the top, even if it was a Friday.
Only 12 trades showing L2, inc one delayed ordinary trade, biggy - 225k.
|fillipe- those sells didn't bring the share price down so that must be a good sign.|
|Long term view been in for 2 years.. Patience and steady upwards will be fine for me|
|COS being sold off a bit this morning after the strong rises
Needs watching as the rise was on not particularly strong buying, except that of the dirs.
|Sold some stock to grab some more.|
|Movement continues at GWMO £1.1m market cap. Multibagger coming.|
|update from beaufort,
Collagen Solutions delivered strong performance in FY 2016 on both operational and financial fronts. The company's FY 2016 revenue was more than three times its FY 2015 revenue, well ahead of market expectations. Revenue from North America soared 231% to £1.8m, benefitting from the acquisition of Southern Lights Biomaterials and organic growth from a broad base of existing customers. Revenue from Asia advanced 311% to £1.2m, making it the fastest-growing region, driven by customer growth from the existing Southern Lights Biomaterials base. Collagen Solutions participated in various collaboration projects with leading academic and industry partners. The company made investments in global R&D facilities and sales and marketing operations to enhance its global presence. The acquisition of ChondroMimetic offers a regenerative orthopaedics platform for cartilage, bone, meniscus, tendon and ligament surgery. Collagen Solutions would commercialize the platform through licensing and distribution partnerships. We are buoyed by the company's progress and results in FY 2015 and look forward to
|Got a few more .. 19k trade .. Added and shoulda bought two pence cheaper I watch it that much hehe But all good,brill prospects, story on line,easy beatable forecasts, on radar now, and share price not aligned with fickle ftse as much as others . Good luck hold long term then reap the rewards of patience|
|grabbed a few of these.|